Learn More
Medchemexpress LLC Methylprednisolone succinate (sodium) | 2375-03-3 | ≥95% | 5 MG

Supplier: Medchemexpress LLC HYB10605MG
Methylprednisolone succinate sodium is a prodrug of Methylprednisolone and a glucocorticoid with immunosuppressant and anti-inflammatory activity. It binds cytosolic glucocorticoid receptors, translocates to nuclei, and modulates target gene transcription. This compound alters Bax, Bcl-2, occludin, and ZO-1 expression; attenuates TLR4/NF-κB signaling; and suppresses proinflammatory cytokine production and immune cell activation. It can be used for research of intracranial haemorrhage, rheumatoid arthritis, multiple sclerosis, preterminal cancer, inflammatory conditions, shock, immediate-type hypersensitivity, acute myocardial ischemia, hypoxic heart muscle damage, and traumatic spinal cord injury.
- Target: glucocorticoid receptor.
- Research areas: infection, neurological disease, inflammation/immunology, cancer.
- Immunosuppressant and anti-inflammatory activity.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.